BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20558599)

  • 1. Alternative splicing of CD200 is regulated by an exonic splicing enhancer and SF2/ASF.
    Chen Z; Ma X; Zhang J; Hu J; Gorczynski RM
    Nucleic Acids Res; 2010 Oct; 38(19):6684-96. PubMed ID: 20558599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping the SF2/ASF binding sites in the bovine growth hormone exonic splicing enhancer.
    Dirksen WP; Li X; Mayeda A; Krainer AR; Rottman FM
    J Biol Chem; 2000 Sep; 275(37):29170-7. PubMed ID: 10880506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cells.
    Guo R; Li Y; Ning J; Sun D; Lin L; Liu X
    PLoS One; 2013; 8(4):e62729. PubMed ID: 23658645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. General splicing factor SF2/ASF promotes alternative splicing by binding to an exonic splicing enhancer.
    Sun Q; Mayeda A; Hampson RK; Krainer AR; Rottman FM
    Genes Dev; 1993 Dec; 7(12B):2598-608. PubMed ID: 8276242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PLP1 alternative splicing in differentiating oligodendrocytes: characterization of an exonic splicing enhancer.
    Wang E; Huang Z; Hobson GM; Dimova N; Sperle K; McCullough A; Cambi F
    J Cell Biochem; 2006 Apr; 97(5):999-1016. PubMed ID: 16288477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative splicing of the adenylyl cyclase stimulatory G-protein G alpha(s) is regulated by SF2/ASF and heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) and involves the use of an unusual TG 3'-splice Site.
    Pollard AJ; Krainer AR; Robson SC; Europe-Finner GN
    J Biol Chem; 2002 May; 277(18):15241-51. PubMed ID: 11825891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative splicing factor or splicing factor-2 plays a key role in intron retention of the endoglin gene during endothelial senescence.
    Blanco FJ; Bernabeu C
    Aging Cell; 2011 Oct; 10(5):896-907. PubMed ID: 21668763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The deep intronic c.903+469T>C mutation in the MTRR gene creates an SF2/ASF binding exonic splicing enhancer, which leads to pseudoexon activation and causes the cblE type of homocystinuria.
    Homolova K; Zavadakova P; Doktor TK; Schroeder LD; Kozich V; Andresen BS
    Hum Mutat; 2010 Apr; 31(4):437-44. PubMed ID: 20120036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway.
    Liu X; Mayeda A; Tao M; Zheng ZM
    J Virol; 2003 Feb; 77(3):2105-15. PubMed ID: 12525645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An erythroid differentiation-specific splicing switch in protein 4.1R mediated by the interaction of SF2/ASF with an exonic splicing enhancer.
    Yang G; Huang SC; Wu JY; Benz EJ
    Blood; 2005 Mar; 105(5):2146-53. PubMed ID: 15522963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel exploitation of a nuclear function by influenza virus: the cellular SF2/ASF splicing factor controls the amount of the essential viral M2 ion channel protein in infected cells.
    Shih SR; Krug RM
    EMBO J; 1996 Oct; 15(19):5415-27. PubMed ID: 8895585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the function of an exonic splicing enhancer after the first catalytic step of pre-mRNA splicing.
    Chew SL; Liu HX; Mayeda A; Krainer AR
    Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10655-60. PubMed ID: 10485881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tra2 beta, SF2/ASF and SRp30c modulate the function of an exonic splicing enhancer in exon 10 of tau pre-mRNA.
    Kondo S; Yamamoto N; Murakami T; Okumura M; Mayeda A; Imaizumi K
    Genes Cells; 2004 Feb; 9(2):121-30. PubMed ID: 15009090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SR proteins ASF/SF2 and SRp55 participate in tissue factor biosynthesis in human monocytic cells.
    Tardos JG; Eisenreich A; Deikus G; Bechhofer DH; Chandradas S; Zafar U; Rauch U; Bogdanov VY
    J Thromb Haemost; 2008 May; 6(5):877-84. PubMed ID: 18315555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of SRp20 exon 4 splicing.
    Jumaa H; Nielsen PJ
    Biochim Biophys Acta; 2000 Nov; 1494(1-2):137-43. PubMed ID: 11072076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SR proteins Asf/SF2 and 9G8 interact to activate enhancer-dependent intron D splicing of bovine growth hormone pre-mRNA in vitro.
    Li X; Shambaugh ME; Rottman FM; Bokar JA
    RNA; 2000 Dec; 6(12):1847-58. PubMed ID: 11142383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eight nucleotide substitutions inhibit splicing to HPV-16 3'-splice site SA3358 and reduce the efficiency by which HPV-16 increases the life span of primary human keratinocytes.
    Li X; Johansson C; Cardoso Palacios C; Mossberg A; Dhanjal S; Bergvall M; Schwartz S
    PLoS One; 2013; 8(9):e72776. PubMed ID: 24039800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine/serine-rich protein interaction domain-dependent modulation of a tau exon 10 splicing enhancer: altered interactions and mechanisms for functionally antagonistic FTDP-17 mutations Delta280K AND N279K.
    D'Souza I; Schellenberg GD
    J Biol Chem; 2006 Feb; 281(5):2460-9. PubMed ID: 16308321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20.
    Galiana-Arnoux D; Lejeune F; Gesnel MC; Stevenin J; Breathnach R; Del Gatto-Konczak F
    J Biol Chem; 2003 Aug; 278(35):32943-53. PubMed ID: 12826680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
    Dauksaite V; Akusjärvi G
    Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.